Over the past decade, cannabis has shifted from taboo to a regulated global industry, with expanding legalization, medical adoption, and economic impact. Yet in 2026, early “Green Rush” expectations have given way to a more complex reality shaped by bureaucracy, uneven policies, and ongoing cultural and political debate. Riding the wave of social media trends… Keep Reading
By Hirsh Jain via Cannabis Confidential newsletter. Subscribe here. How Zorn’s trajectory from litigator to policymaker echoes Thurgood Marshall. As we look back on the most consequential week in the modern history of American drug policy, much of the attention and fanfare has focused on President Trump, and for good reason. Trump displayed a unique… Keep Reading
From tip fatigue to tip theft, the humble dispensary tip jar has become a window into some of the cannabis industry’s biggest unresolved labor questions. It’s just a jar on a counter, but the tip jar at the dispensary has a way of making things complicated. Some consumers happily toss a few dollars in appreciation… Keep Reading
On April 23, 2026, the Trump administration moved medical marijuana from Schedule I to Schedule III — the biggest federal cannabis policy shift in decades. It was historic. It was also incomplete. Tens of thousands of Americans remain incarcerated for cannabis offenses that are now legal in most of the country. Advocates say rescheduling without… Keep Reading
The Trump administration is preparing to move cannabis from Schedule I to Schedule III of the Controlled Substances Act as soon as today, according to reporting from Axios. This would mark the most significant federal cannabis policy shift in decades. It is not legalization. Here’s what you need to know right now. As of publication,… Keep Reading
The drug’s history of healing and experimentation stretches from ancient China to American counterculture — yet its promise remains trapped in a legal straitjacket. This article is adapted from The MIT Press Reader and reprinted with permission. It is adapted from Cannabinoids by Linda A. Parker, published by MIT Press. An altered state of consciousness,… Keep Reading
From home labs and deadly butane blasts to solventless rosin, police raids, and a legal gray zone, Spain is entering a more potent and more volatile phase of cannabis culture. On a cold night in late January 2025, a home lab in Espinardo (Murcia) ended in tragedy. Two young men were killed when a butane-based… Keep Reading
Ali and Muha Garawi built Muha Meds from a $15,000 startup into one of cannabis’s most dominant brands — without outside money, without losing the culture and without losing each other. “A lot of people wait for the right moment or for some perfect circumstance,” says Muha Garawi, “but when you have a background like… Keep Reading
From medical rumors to a possible upper-crust grow op, a new story is once again linking King Charles III to cannabis. This time, however, it has nothing to do with health speculation or the monarch’s well-known passion for botany. Instead, the connection comes by way of a police raid at a historic property tied to… Keep Reading
A Travis County judge temporarily blocked Texas from enforcing new hemp rules that had effectively pushed smokable THCA flower and pre-rolls off shelves. For now, the fight is back in court, and back in business. Texas tried to shut the door on smokable hemp. A judge just cracked it back open. A Travis County district… Keep Reading
